Mainland China, Taiwan Set To Collaborate On Vaccine R&D, Start Year-End Trials
This article was originally published in PharmAsia News
Executive SummaryContinental China and Taiwan have agreed on major elements of an agreement for cooperation in producing vaccines
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.